Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/jamadermatol.2015.2878 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Hispanic/Latino communities in the US are rapidly growing and aging and are at two-fold risk of Alzheimer's Disease and Related Dementia's (ADRD) compared to non-Hispanic Whites. This additional risk could be, in part, due to increased risk of cardiovascular disease. Hispanics/Latinos also have higher rate of diabetes compared to non-Hispanic Whites and nearly 2 out of 5 individuals with diabetes go undiagnosed.
View Article and Find Full Text PDFBackground: In the EEG research of Alzheimer's Disease (AD) and other diseases belonging to dementia, the literature is rapidly growing to indicate biomarkers specific to the type of dementia. The literature showed firm conclusions that decreasing event-related delta and theta responses could be a biomarker showing cognitive decline (Güntekin et al. 2022).
View Article and Find Full Text PDFPublic Health.
Alzheimers Dement
December 2024
University of California San Francisco School of Nursing, San Francisco, CA, USA.
Background: The Korean American older adult population is rapidly growing, with most being foreign-born individuals with limited English proficiency, and who experience significant health disparities. The Koreans Invested in Making Caregivers Health Important (KIMCHI) project is a national, culturally tailored, bilingual (English/Korean) initiative focused on community-based research dissemination to empower Korean Americans with insights into healthy cognitive aging and dementia caregiving.
Method: From the community partnership with Somang Society and AARIN, a total of 211 participants, predominantly older adults (aged 24- 90 years; M = 69; SD = 12.
Public Health.
Alzheimers Dement
December 2024
Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Background: The prevalence of Alzheimer disease (AD) is growing rapidly within the aging population with over five million people currently affected in the United States. Of these 5 million people, approximately two-thirds are females. Prior investigations have demonstrated that females have a higher likelihood of developing AD when compared to men.
View Article and Find Full Text PDFBackground: The rapidly growing pipeline of target-specific Alzheimer's Disease (AD) therapeutic candidates requires accompanying tests that can identify patients likely to have a beneficial response. The growing importance of multiple pathologies in determining AD progression and treatment response underscores this need. Our work focuses on establishing analytical capability to expand detectable forms of major protein drug targets for AD: Tau, amyloid beta (Ab) and a-Synuclein (aS) proteoforms as potential personalized molecular signatures.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!